Annual revenue for 2025 was $1,489,427, a 61% decrease from $3,824,301 in 2024. Net loss for 2025 was $2,042,463, compared to a net loss of $2,768,341 in 2024. The company reports a working capital deficit of $7,476,418 as of December 31, 2025. Cash and cash equivalents decreased to $20,751 from $62,310 during the fiscal year. The company operates four segments: direct sales, pharmacy, hotel, and manufacture and sale.